GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OTCPK:CLPBF) » Definitions » Net Interest Income

CLPBF (Coloplast AS) Net Interest Income : $-105 Mil (TTM As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Coloplast AS Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Coloplast AS's net interest income for the three months ended in Dec. 2024 was $-23 Mil. Its net interest income for the trailing twelve months (TTM) ended in Dec. 2024 was $-105 Mil.


Coloplast AS Net Interest Income Historical Data

The historical data trend for Coloplast AS's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Net Interest Income Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Net Interest Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.55 -7.12 -26.21 -86.44 -107.92

Coloplast AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.53 -24.05 -29.28 -28.28 -23.17

Coloplast AS Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-105 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Coloplast AS Net Interest Income Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

From GuruFocus

Q2 2022 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2024 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 08-21-2024

Q2 2024 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 05-08-2024

Q1 2022 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Coloplast A/S Virtual ESG Event Call Transcript

By GuruFocus Research 02-13-2024

Q4 2024 Coloplast A/S Earnings Call Transcript

By GuruFocus News 11-06-2024

Coloplast A/S to Acquire Atos Medical Call Transcript

By GuruFocus Research 02-13-2024

Q4 2021 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024